Literature DB >> 33197399

Assessing the Physiologic Endotypes Responsible for REM and NREM Based OSA.

Simon A Joosten1, Shane A Landry2, Ai-Ming Wong3, Dwayne L Mann4, Philip I Terrill4, Scott A Sands5, Anthony Turton6, Caroline Beatty2, Luke Thomson2, Garun S Hamilton7, Bradley A Edwards2.   

Abstract

BACKGROUND: Patients with OSA can have the majority of their respiratory events in rapid eye movement (REM) sleep or in non-rapid eye movement (NREM) sleep. No previous studies have linked the different physiologic conditions in REM and NREM sleep to the common polysomnographic patterns seen in everyday clinical practice, namely REM predominant OSA (REMOSA) and NREM predominant OSA (NREMOSA). RESEARCH QUESTION: (1) How does OSA physiologic condition change with sleep stage in patients with NREMOSA and REMOSA? (2) Do patients with NREMOSA and REMOSA have different underlying OSA pathophysiologic conditions? STUDY DESIGN AND METHODS: We recruited patients with three polysomnographic patterns. (1) REMOSA: twice as many respiratory events in REM sleep, (2) NREMOSA: twice as many events in NREM sleep, and (3) uniform OSA: equal number of events in NREM/REM sleep. We deployed a noninvasive phenotyping method to determine OSA endotype traits (Vpassive, Vactive, loop gain, arousal threshold) in NREM sleep, REM sleep, and total night sleep in each group of patients (NREMOSA, REMOSA, uniform OSA).
RESULTS: Patients with NREMOSA have significantly worse ventilatory control stability in NREM sleep compared with REM sleep (loop gain, 0.546 [0.456,0.717] in NREM vs 0.365 [0.238,0.459] in REM sleep; P = .0026). Patients with REMOSA displayed a significantly more collapsible airway (ie, lower Vpassive) in REM compared with NREM sleep (98.4 [97.3,99.2] %Veupnea in NREM vs 95.9 [86.4,98.9] %Veupnea in REM sleep; P < .0001). The major between-group difference across the whole night was a significantly higher loop gain in the NREMOSA group (0.561 [0.429,0.675]) compared with the REMOSA group (0.459 [0.388,0.539]; P = .0033).
INTERPRETATION: This study is the first to link long-recognized polysomnographic patterns of OSA to underlying physiologic differences. Patients with NREMOSA have a higher loop gain in NREM sleep; patients with REMOSA have a worsening of Vpassive in REM sleep.
Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  OSA; REM sleep; phenotype

Year:  2020        PMID: 33197399     DOI: 10.1016/j.chest.2020.10.080

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  Rapamycin ameliorates chronic intermittent hypoxia and sleep deprivation-induced renal damage via the mammalian target of rapamycin (mTOR)/NOD-like receptor protein 3 (NLRP3) signaling pathway.

Authors:  Wei Liu; Dong Zhao; Xiaofeng Wu; Fang Yue; Haizhen Yang; Ke Hu
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

2.  An Attention-Guided Spatiotemporal Graph Convolutional Network for Sleep Stage Classification.

Authors:  Menglei Li; Hongbo Chen; Zixue Cheng
Journal:  Life (Basel)       Date:  2022-04-21

3.  Ventilatory Drive Withdrawal Rather Than Reduced Genioglossus Compensation as a Mechanism of Obstructive Sleep Apnea in REM Sleep.

Authors:  Ludovico Messineo; Danny J Eckert; Luigi Taranto-Montemurro; Daniel Vena; Ali Azarbarzin; Lauren B Hess; Nicole Calianese; David P White; Andrew Wellman; Laura Gell; Scott A Sands
Journal:  Am J Respir Crit Care Med       Date:  2022-01-15       Impact factor: 21.405

4.  Multidimensional assessment and cluster analysis for OSA phenotyping.

Authors:  Xiao Lei Zhang; Li Zhang; Yi Ming Li; Bo Yun Xiang; Teng Han; Yan Wang; Chen Wang
Journal:  J Clin Sleep Med       Date:  2022-07-01       Impact factor: 4.324

5.  Dreaming of New Obstructive Sleep Apnea Treatments.

Authors:  Amy S Jordan; Kristina Kairaitis
Journal:  Am J Respir Crit Care Med       Date:  2022-01-15       Impact factor: 21.405

6.  Natural History of REM-OSA in Children and Its Associations with Adverse Blood Pressure Outcomes: A Longitudinal Follow-Up Study.

Authors:  Kate C Chan; Chun T Au; Michelle W Yu; Yun K Wing; Albert M Li
Journal:  Nat Sci Sleep       Date:  2021-11-04

7.  Prevalence and Risk Factors for Rapid Eye Movement-Related Obstructive Sleep Apnea in Children.

Authors:  Surisa Chamnanpet; Prakarn Tovichien; Archwin Tanphaichitr; Wattanachai Chotinaiwattarakul
Journal:  Front Pediatr       Date:  2022-04-28       Impact factor: 3.418

8.  Clinical Characteristics of Rapid Eye Movement-Related Obstructive Sleep Apnea: An Experience in a Tertiary Medical Center of Taiwan.

Authors:  Hwa-Yen Chiu; Yung-Yang Liu; Tsu-Hui Shiao; Kang-Cheng Su; Kun-Ta Chou; Yuh-Min Chen
Journal:  Nat Sci Sleep       Date:  2022-08-31

9.  Physiological Traits and Adherence to Sleep Apnea Therapy in Individuals with Coronary Artery Disease.

Authors:  Andrey V Zinchuk; Jen-Hwa Chu; Jiasheng Liang; Yeliz Celik; Sara Op de Beeck; Nancy S Redeker; Andrew Wellman; H Klar Yaggi; Yüksel Peker; Scott A Sands
Journal:  Am J Respir Crit Care Med       Date:  2021-09-15       Impact factor: 30.528

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.